Walmart to Bet $1.2 Billion on China Logistics, Focusing on Fresh Food Delivery
U.S. retail giant Walmart (NYSE: WMT) announced Monday it will invest 8 billion yuan, or $1.2 billion, to upgrade its logistics in China over the next 10 years.
The company, which entered the Chinese market 22 years ago, said in a statement on its social media account today that it would set up or renovate more than 10 logistics centers in China after the debut of its perishable food distribution center in South China in March.
The retailer has invested more than 700 million yuan, or $104 million, in the South China center in Dongguan of Guangdong Province, which has been the largest investment by Walmart in China.
The South China center, with an area of 33,700 square meters, reportedly handles more than 165,000 packages of goods with refrigeration, freezing, or constant temperature storage.
"Fresh food accounted for one-fourth of Walmart China's overall sales in 2018," Wern-Yuen Tan, the chief executive officer of Walmart China, told China Daily.
"Walmart China also plans to continue to grow its Marketside fresh foods private brands. Overall, the retailer's private brands grew 30 percent in 2018," Wern-Yuen added.
Walmart currently has eight dry warehouse distribution centers and 11 fresh food distribution centers in China.
Walmart China suffered sales below average in the first quarter. Its revenue from the Chinese market dropped 4 percent to $3.6 billion in the three months through March from the same period a year ago, according to the quarterly financial statement the company released in early June.
The logistics unit of online retailer JD.com Inc. (Nasdaq: JD), in which Walmart owns a stake, is reportedly seeking an initial public offering, though it has not publicly filed a prospectus.
(Reuters contributed to this article)
36Kr Raises $20 Million in New York IPO; Stock Tumbles on Debut
Pingtan Stock Plunges 14% on Weak Sales, Net Income Drop
Bright Scholar's Shares Slip 2% on Losses, Market Uncertainty
Nio and Intel to Jointly Launch L4 Model
Tencent Music's Revenue Growth Offset by Decline in Sublicensing
Cellular Biomedicine Up 1% on Buyout Proposal